Nerve Growth Factor in Cancer Cell Death and Survival
暂无分享,去创建一个
A. Gorman | Adrienne M. Gorman | Niamh H. Molloy | Danielle E. Read | D. E. Read | Niamh H N Molloy | N. Molloy
[1] T. Hatae,et al. Effect of 3-methyladenine on the fusion process of macropinosomes in EGF-stimulated A431 cells. , 2006, Cell structure and function.
[2] E. Coulson,et al. The p75 neurotrophin receptor. , 2008, The international journal of biochemistry & cell biology.
[3] M. Lenardo,et al. Competitive Control of Independent Programs of Tumor Necrosis Factor Receptor-Induced Cell Death by TRADD and RIP1 , 2006, Molecular and Cellular Biology.
[4] Yongliang Zhu,et al. Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells. , 2008, Carcinogenesis.
[5] M. Karin. Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.
[6] L. Buscail,et al. [Molecular pathways of pancreatic carcinogenesis]. , 2002, Annales de pathologie.
[7] R. Warrington,et al. Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis , 2011, Cancer Immunology, Immunotherapy.
[8] C. Hauser,et al. TRAF Family Proteins Interact with the Common Neurotrophin Receptor and Modulate Apoptosis Induction* , 1999, The Journal of Biological Chemistry.
[9] R. Ho,et al. Trk Receptor Expression and Inhibition in Neuroblastomas , 2009, Clinical Cancer Research.
[10] C. Hertel,et al. NGF induces apoptosis in a human neuroblastoma cell line expressing the neurotrophin receptor p75NTR , 1998, Journal of neuroscience research.
[11] I. Gromova,et al. Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients , 2005, Molecular & Cellular Proteomics.
[12] S. Martin,et al. The CASBAH: a searchable database of caspase substrates , 2007, Cell Death and Differentiation.
[13] L. Platanias,et al. Autophagy Is a Critical Mechanism for the Induction of the Antileukemic Effects of Arsenic Trioxide* , 2010, The Journal of Biological Chemistry.
[14] Junying Yuan,et al. Autophagy in cell death: an innocent convict? , 2005, The Journal of clinical investigation.
[15] Devrim Gozuacik,et al. Autophagy and cell death. , 2007, Current topics in developmental biology.
[16] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[17] M. Karin. Nuclear factor-κB in cancer development and progression , 2006, Nature.
[18] M. Barbacid,et al. The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.
[19] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[20] E. Castellón,et al. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma , 2005, The Prostate.
[21] M. Barbacid,et al. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences , 1986, Nature.
[22] A Jusić,et al. On the death. , 1993, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[23] Petti T. Pang,et al. The yin and yang of neurotrophin action , 2005, Nature Reviews Neuroscience.
[24] W. Hamel,et al. Autophagic cell death induced by TrkA receptor activation in human glioblastoma cells , 2007, Journal of neurochemistry.
[25] H. Hondermarck,et al. Tumor Necrosis Factor Receptor-associated Death Domain Protein Is Involved in the Neurotrophin Receptor-mediated Antiapoptotic Activity of Nerve Growth Factor in Breast Cancer Cells* , 2003, The Journal of Biological Chemistry.
[26] M. Karin,et al. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. , 2009 .
[27] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[28] A. Klein-Szanto,et al. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] M. Chao,et al. Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.
[30] P. Lazarovici,et al. Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. , 2001, Cancer research.
[31] P. Vigneri,et al. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[32] H. Hondermarck,et al. Nerve growth factor is a potential therapeutic target in breast cancer. , 2008, Cancer research.
[33] K. Courneya,et al. Cardiovascular Risk Profile of Patients with HER2/neu-Positive Breast Cancer Treated with Anthracycline-Taxane–Containing Adjuvant Chemotherapy and/or Trastuzumab , 2007, Cancer Epidemiology Biomarkers & Prevention.
[34] L. Tessarollo. Pleiotropic functions of neurotrophins in development. , 1998, Cytokine & growth factor reviews.
[35] H. Hondermarck,et al. Nerve growth factor overexpression and autocrine loop in breast cancer cells , 2003, Oncogene.
[36] C. Montagnoli,et al. Novel localization of low affinity NGF receptor (p75) in the stroma of prostate cancer and possible implication in neoplastic invasion: An immunohistochemical and ultracytochemical study , 2010, The Prostate.
[37] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[38] Rebecca C Taylor,et al. Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.
[39] S. Mörk,et al. On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak , 2002, Acta Neuropathologica.
[40] D. Djakiew,et al. The neurotrophin receptor p75NTR is a tumor suppressor in human prostate cancer. , 2001, Anticancer research.
[41] John L Cleveland,et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.
[42] C. Ibáñez,et al. Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle , 2006, The EMBO journal.
[43] D. Bostwick,et al. Human prostate cancer risk factors , 2004, Cancer.
[44] K. Turlejski,et al. Neurotrophins and their receptors in early development of the mammalian nervous system. , 2010, Acta neurobiologiae experimentalis.
[45] Vasudevan Seshadri,et al. Translational control by the 3'-UTR: the ends specify the means. , 2003, Trends in biochemical sciences.
[46] X. Wang,et al. Characterization of a p75NTR Apoptotic Signaling Pathway Using a Novel Cellular Model* , 2001, The Journal of Biological Chemistry.
[47] Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors. , 2000, Molecular endocrinology.
[48] E. Germain,et al. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways , 2010, Molecular Cancer.
[49] T. Schnitzer,et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. , 2010, New England Journal of Medicine.
[50] T. Yamashita,et al. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI , 2003, Nature Neuroscience.
[51] Michael Karin,et al. Is NF-κB a good target for cancer therapy? Hopes and pitfalls , 2009, Nature Reviews Drug Discovery.
[52] E. Huang,et al. Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.
[53] R. Levi‐montalcini,et al. Nerve growth factor. , 1975, Science.
[54] L. Reichardt,et al. Neurotrophin-regulated signalling pathways , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[55] R. Levi‐montalcini,et al. EFFECT OF A NERVE GROWTH FACTOR ON GLUCOSE METABOLISM BY SYMPATHETIC AND SENSORY NERVE CELLS. , 1964, Biochimica et biophysica acta.
[56] S. Tóth,et al. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. , 2000, Cytokine.
[57] B. Pettmann,et al. Signaling by death receptors in the nervous system , 2008, Current Opinion in Neurobiology.
[58] P. Barker. p75NTR Is Positively Promiscuous Novel Partners and New Insights , 2004, Neuron.
[59] E. Ricevuto,et al. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. , 2007, International journal of oncology.
[60] M. Ciotti,et al. Role of the autophagic‐lysosomal system on low potassium‐induced apoptosis in cultured cerebellar granule cells , 2005, Journal of neurochemistry.
[61] A. Naderi,et al. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer , 2010, Molecular Cancer.
[62] P. Grob,et al. Purification and Amino Terminal Sequencing of Human Melanoma Nerve Growth Factor Receptor , 1987, Journal of neurochemistry.
[63] G. Khursigara,et al. Association of the p75 Neurotrophin Receptor with TRAF6* , 1999, The Journal of Biological Chemistry.
[64] J. Isaacs,et al. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555). , 1999, Cancer research.
[65] D. Djakiew,et al. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines. , 1996, Journal of andrology.
[66] L. French,et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. , 2008, The Journal of investigative dermatology.
[67] C. Ibáñez,et al. Assembly and activation of neurotrophic factor receptor complexes , 2010, Developmental neurobiology.
[68] D. Djakiew,et al. Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor–induced cell growth by activation of programmed cell death , 1998, Molecular carcinogenesis.
[69] N. Neff,et al. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[70] D. Schmidt,et al. NGF ligand alters NGF signaling via p75NTR and TrkA , 2000, Journal of neuroscience research.
[71] Barbara L. Hempstead,et al. Sortilin is essential for proNGF-induced neuronal cell death , 2004, Nature.
[72] V. Hamburger,et al. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. , 1951, The Journal of experimental zoology.
[73] H. Hondermarck,et al. Nerve Growth Factor Is Mitogenic for Cancerous but Not Normal Human Breast Epithelial Cells* , 1998, The Journal of Biological Chemistry.
[74] D. Djakiew,et al. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: A role in selective neurotrophin stimulation of prostate epithelial cell growth , 1999, The Prostate.
[75] Paula Hanger,et al. To the Death , 1950 .
[76] M. Herlyn,et al. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. , 1991, The Journal of investigative dermatology.
[77] Zahra Zakeri,et al. Apoptosis, autophagy, and more. , 2004, The international journal of biochemistry & cell biology.
[78] F. Révillion,et al. Expression of nerve growth factor receptors and their prognostic value in human breast cancer. , 2001, Cancer research.
[79] J. Tschopp,et al. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. , 2004, Immunity.
[80] F. Longo,et al. Small molecule modulation of p75 neurotrophin receptor functions. , 2008, CNS and Neurological Disorders - Drug Targets.
[81] A. Tolkovsky,et al. Autophagy Is Activated by Apoptotic Signalling in Sympathetic Neurons: An Alternative Mechanism of Death Execution , 1999, Molecular and Cellular Neuroscience.
[82] A. Naderi,et al. BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer , 2009, International journal of cancer.
[83] Michael Karin,et al. NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.
[84] D. Djakiew,et al. Molecular characterization of the loss of p75NTR expression in human prostate tumor cells , 2001, Molecular carcinogenesis.
[85] J. Nesland,et al. Altered Expression and Activation of the Nerve Growth Factor Receptors TrkA and p75 Provide the First Evidence of Tumor Progression to Effusion in Breast Carcinoma , 2004, Breast Cancer Research and Treatment.
[86] Y. Shukla,et al. Death receptors: targets for cancer therapy. , 2010, Experimental cell research.
[87] O. Grace,et al. The role of smooth muscle in regulating prostatic induction. , 2002, Development.
[88] S. Byers,et al. The p75NTR mediates a bifurcated signal transduction cascade through the NF kappa B and JNK pathways to inhibit cell survival. , 2005, Experimental cell research.
[89] E. Shooter,et al. Early days of the nerve growth factor proteins. , 2001, Annual review of neuroscience.
[90] D. Marchetti,et al. Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells , 2004, Clinical & Experimental Metastasis.
[91] M. Greenberg,et al. New Insights in the Biology of BDNF Synthesis and Release: Implications in CNS Function , 2009, The Journal of Neuroscience.
[92] M. Bothwell,et al. Neurotrophin receptors: Old friends with new partners , 2010, Developmental neurobiology.
[93] A. Geldof,et al. Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells , 1997, Journal of Cancer Research and Clinical Oncology.
[94] D. Djakiew,et al. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. , 1993, Cancer research.
[95] R. Riopelle,et al. Differential Activity of the Nerve Growth Factor (NGF) Antagonist PD90780 [7-(Benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic Acid] Suggests Altered NGF-p75NTR Interactions in the Presence of TrkA , 2004, Journal of Pharmacology and Experimental Therapeutics.
[96] P. Bastiaens,et al. Activation of the p75 Neurotrophin Receptor through Conformational Rearrangement of Disulphide-Linked Receptor Dimers , 2009, Neuron.
[97] W. Filipowicz,et al. Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.
[98] D. Djakiew,et al. Neurotrophin receptor p75NTR suppresses growth and nerve growth factor‐mediated metastasis of human prostate cancer cells , 2002 .
[99] E. Jung,et al. The reduced catalase expression in TrkA-induced cells leads to autophagic cell death via ROS accumulation , 2008 .
[100] Philippe P Roux,et al. Neurotrophin signaling through the p75 neurotrophin receptor , 2002, Progress in Neurobiology.
[101] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[102] H. Hondermarck,et al. Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications , 2010, Breast Cancer Research and Treatment.
[103] W. Friedman,et al. Mechanisms of p75-mediated Death of Hippocampal Neurons , 2002, The Journal of Biological Chemistry.
[104] M. A. Pierotti,et al. Rearrangements of NTRK1 gene in papillary thyroid carcinoma , 2010, Molecular and Cellular Endocrinology.
[105] D. Djakiew. Dysregulated expression of growth factors and their receptors in the development of prostate cancer , 2000, The Prostate.
[106] Lorenzo Galluzzi,et al. To die or not to die: that is the autophagic question. , 2008, Current molecular medicine.
[107] Joachim Weis,et al. The Dark Side of the NGF Family: Neurotrophins in Neoplasias , 2006, Brain pathology.
[108] H. Hondermarck,et al. Nerve growth factor receptors and signaling in breast cancer. , 2004, Current cancer drug targets.
[109] D. Djakiew,et al. Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. , 2002, International journal of cancer.
[110] P. Vandenabeele,et al. The caspase family , 2003 .
[111] P. Spano,et al. Nerve growth factor signaling in prostate health and disease , 2010, Growth factors.
[112] X. Montano,et al. Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer , 2004, FEBS letters.
[113] J. Peyrat,et al. Nerve Growth Factor Stimulates Proliferation and Survival of Human Breast Cancer Cells through Two Distinct Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[114] P. S. Amieux,et al. Proteolytic Processing of the p75 Neurotrophin Receptor and Two Homologs Generates C-Terminal Fragments with Signaling Capability , 2003, The Journal of Neuroscience.
[115] D. Djakiew,et al. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. , 1992, Cancer research.
[116] N. Schor. The p75 neurotrophin receptor in human development and disease , 2005, Progress in Neurobiology.
[117] H. Friess,et al. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells , 2002, Molecular carcinogenesis.
[118] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[119] D. Djakiew,et al. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. , 1992, The Journal of urology.
[120] J. Wood. Nerve growth factor and pain. , 2010, The New England journal of medicine.
[121] J. Bertin,et al. A Prosurvival Function for the p75 Receptor Death Domain Mediated via the Caspase Recruitment Domain Receptor-Interacting Protein 2 , 2001, The Journal of Neuroscience.
[122] Craig B. Thompson,et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes , 2004, Nature Cell Biology.
[123] M. Chao,et al. Mechanisms of neurotrophin receptor signalling. , 2006, Biochemical Society transactions.
[124] R. Toillon,et al. TrkA overexpression enhances growth and metastasis of breast cancer cells , 2009, Oncogene.
[125] E. Karaca,et al. Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor , 2009, Journal of Cell Science.
[126] A. Weeraratna,et al. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[127] D. Djakiew,et al. Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate , 1997, Molecular and Cellular Endocrinology.
[128] S. Meakin,et al. Nerve growth factor activation of the TrkA receptor induces cell death, by macropinocytosis, in medulloblastoma Daoy cells , 2010, Journal of neurochemistry.
[129] Fatima S. Khwaja,et al. The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. , 2006, Biochemical and biophysical research communications.
[130] Barbara Costa,et al. On the death Trk , 2010, Developmental neurobiology.